| Patent Number |
Title Of Patent |
Date Issued |
| 6190351 |
Nutritional support system |
February 20, 2001 |
| A nutritional system is disclosed, for delivering a colorant dye to a nutritional fluid that flows through the nutritional system. |
| 5925015 |
Nutritional support system |
July 20, 1999 |
| A nutritional system is disclosed, for delivering a colorant dye to a nutritional fluid that flows through the nutritional system. |
| 5897878 |
Method for administering steroid |
April 27, 1999 |
| A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, l |
| 5869096 |
Oral osmotic device with hydrogel driving member |
February 9, 1999 |
| An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a wall (12) |
| 5842476 |
Method for controlling fertility |
December 1, 1998 |
| An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a female, and a compartment comprising an estrogenic steroid that is delivered at a controlle |
| 5830501 |
Dosage form comprising hydrophilic polymer |
November 3, 1998 |
| A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, l |
| 5776493 |
Oral osmotic device for delivery of nystatin with hydrogel driving member |
July 7, 1998 |
| An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a wall (12) |
| 5718700 |
Exit means in dosage form |
February 17, 1998 |
| A dosage form is disclosed comprising a wall that surrounds a bilayer core with exit passageway for communicating with the bilayer core in the wall. |
| 5595759 |
Process for providing therapeutic composition |
January 21, 1997 |
| A process is disclosed and claimed for preparing a therapeutic composition comprising asteroid or a dosage form comprising the composition, which therapeutic composition or dosage form is indicated for human administration. |
| 5573776 |
Oral osmotic device with hydrogel driving member |
November 12, 1996 |
| An osmotic device (10) for delivering an ergot alkaloid into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a wall (12) surrounding a compartment ( |
| 5413572 |
Osmotic dosage system for liquid drug delivery |
May 9, 1995 |
| An osmotic system is disclosed for delivering a beneficial agent formulation to an environment of use. The osmotic system comprises (a) an outside semipermeable wall, (b) a middle osmotically active layer, (c) a capsule comprising a beneficial agent, and (d) a passageway for dispensing |
| 5348746 |
Method for administering drug |
September 20, 1994 |
| A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, l |
| 5326571 |
Dosage forms comprising polymers comprising different molecular weights |
July 5, 1994 |
| A dosage form is disclosed comprising a wall surrounding a compartment, which comprises a first composition comprising a carboxymethylcellulose and a second composition comprising a higher molecular weight carboxymethylcellulose. The first composition comprises a dosage amount of dru |
| 5324280 |
Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
June 28, 1994 |
| An osmotic system is disclosed for delivering a beneficial agent formulation to an environment of use. The osmotic system comprises (a) an outside semipermeable wall, (b) a middle osmotically active layer, (c) a capsule comprising a beneficial agent, and (d) a passageway for dispensing |
| 5266332 |
Method for administering anti-Parkinson drug |
November 30, 1993 |
| A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, l |
| 5254349 |
Process for lessening irritation caused by drug |
October 19, 1993 |
| A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, l |
| 5248310 |
Oral osmotic device with hydrogel driving member |
September 28, 1993 |
| An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a wall (12) |
| 5208037 |
Dosage forms comprising polymers comprising different molecular weights |
May 4, 1993 |
| A dosage form is disclosed comprising a wall surrounding a compartment, which comprises a first composition comprising a carboxymethylcellulose and a second composition comprising a higher molecular weigh carboxymethylcellulose. The first composition comprises a dosage amount of drug |
| 5200197 |
Contraceptive pill |
April 6, 1993 |
| An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a female, and a compartment comprising an estrogenic steroid that is delivered at a controlle |
| 5200195 |
Process for improving dosage form delivery kinetics |
April 6, 1993 |
| A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, l |
| 5147654 |
Oral osmotic device for delivering nicotine |
September 15, 1992 |
| An osmotic device (10) for the controlled systemic delivery of nicotine through an oral mucosal membrane of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a |
| 5098714 |
Osmotic, oral dosage form for fertility control |
March 24, 1992 |
| An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a female, and a compartment comprising an estrogenic steroid that is delivered at a controlle |
| 5082668 |
Controlled-release system with constant pushing source |
January 21, 1992 |
| A device is disclosed comprising a wall that surrounds a compartment. The compartment comprises a beneficial agent composition and a push composition. A passageway in the wall connects the compartment with the exterior of the device for delivering the beneficial agent at a rate gover |
| 5053032 |
Method of signalling a patient during buccal agent delivery |
October 1, 1991 |
| An osmotic device for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device comprises a wall surrounding a compartm |
| 5028434 |
Method for administering nilvadipine for treating cardiovascular symptoms |
July 2, 1991 |
| A dosage form is disclosed comprising nilvadipine for administering to a patient in need of cardiovascular therapy. |
| 5021053 |
Oral osmotic device with hydrogel driving member |
June 4, 1991 |
| An osmotic device for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device comprises a wall surrounding a compartm |
| 4902514 |
Dosage form for administering nilvadipine for treating cardiovascular symptoms |
February 20, 1990 |
| A dosage form is disclosed comprising nilvadipine for administering to a patient in need of cardiovascular therapy. |
| 4837111 |
Dosage form for dispensing drug for human therapy |
June 6, 1989 |
| An osmotic dosage system is disclosed for delivering the therapeutically beneficial drug doxazosin to an environment of use over time. |
| 4783337 |
Osmotic system comprising plurality of members for dispensing drug |
November 8, 1988 |
| An osmotic system is disclosed comprising a wall comprising in at least a part of a semipermeable material that surrounds a compartment. The compartment contains a first osmotic composition comprising a beneficial drug selected from the group consisting of a calcium antagonist, angio |
| 4765989 |
Osmotic device for administering certain drugs |
August 23, 1988 |
| An osmotic system is disclosed comprising a wall comprising in at least a part of a semipermeable material that surrounds a compartment. The compartment contains an osmotic composition comprising a beneficial drug selected from the group consisting of nifedipine, prazosin and doxazosin, |
